Related Experiment Video

Updated: May 30, 2026

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in

Delphine Javelaud1, Vasileia-Ismini Alexaki, Marie-Jeanne Pierrat

  • 1Institut Curie, Centre de Recherche, Orsay, France.

Pigment Cell & Melanoma Research
|August 2, 2011
PubMed

Insights

High GLI2 expression in melanoma promotes invasiveness by suppressing melanocyte differentiation factor M-MITF. This balance is regulated by TGF-β and PKA/cAMP pathways, impacting melanoma cell plasticity and spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • GLI2, a key GLI transcription factor, is a direct TGF-β/SMAD target implicated in melanoma invasiveness.
  • Melanoma cell phenotype is influenced by the balance between GLI2 and melanocyte-specific transcription factor M-microphthalmia transcription factor (M-MITF).

Purpose of the Study:

  • To investigate the regulatory relationship between GLI2 and M-MITF in melanoma.
  • To elucidate the pathways controlling the balance between GLI2 and M-MITF.
  • To determine the functional impact of GLI2 and M-MITF on melanoma cell invasion and differentiation.

Main Methods:

  • Correlation analysis of GLI2 and M-MITF expression in melanoma cell lines.
  • Assessment of melanocytic differentiation markers and pigmentation.
  • Overexpression and knockdown experiments for GLI2 and M-MITF.
  • Analysis of TGF-β and PKA/cAMP pathway involvement.

Main Results:

  • High GLI2 expression inversely correlates with M-MITF expression and melanocytic differentiation markers.
  • GLI2-expressing cells show reduced pigmentation and M-MITF-dependent markers.
  • TGF-β pathway promotes GLI2, while PKA/cAMP pathway promotes M-MITF.
  • GLI2 and M-MITF reciprocally repress each other and oppositely regulate melanoma cell invasion.

Conclusions:

  • GLI2 antagonizes M-MITF function, promoting melanoma cell phenotypic plasticity and invasive behavior.
  • The balance between GLI2 and M-MITF is a critical determinant of melanoma progression.
  • Targeting the GLI2/M-MITF axis offers potential therapeutic strategies for melanoma.

More Related Videos

Experimental Metastasis Assay08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...